Rosacea: I. Etiology, pathogenesis, and subtype classification

Journal of the American Academy of Dermatology

Volumn 51, Issue 3, 2004, Pages 327-341

  Crawford, Glen H ^a   Pelle, Michelle T ^a   James, William D ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; CYANOCOBALAMIN; ISOTRETINOIN; METRONIDAZOLE; NICOTINIC ACID; PYRIDOXINE; STEROID; SULFUR; TACROLIMUS; TETRACYCLINE;

ALLERGIC RHINITIS; CHALAZIA; CLIMATE; CLINICAL FEATURE; DEGENERATION; DEMODEX; DIAGNOSTIC TEST; DIET; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG ERUPTION; DRUG USE; ERYTHEMA; ERYTHEMATOTELANGIECTATIC ROSACEA; FLUSHING; GASTROINTESTINAL DISEASE; GLANDULAR ROSACEA; HELICOBACTER PYLORI; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; LABORATORY TEST; OCULAR ROSACEA; PAPULE; PAPULOPUSTULAR ROSACEA; PATCH TEST; PATHOGENESIS; PERIORAL DERMATITIS; PHOTOSENSITIVITY; PHYMATOUS ROSACEA; PRIORITY JOURNAL; PUSTULE; REVIEW; ROSACEA; SIDE EFFECT; SKIN SURGERY; SUN EXPOSURE; SURGICAL TECHNIQUE; TELANGIECTASIA; VASCULARIZATION;

ADRENAL CORTEX HORMONES; DIET; EXPERT TESTIMONY; EXTRACELLULAR MATRIX; FEMALE; FLUSHING; FORECASTING; HAIR FOLLICLE; HELICOBACTER INFECTIONS; HUMANS; IRRITANTS; MALE; MITE INFESTATIONS; PHOTOSENSITIVITY DISORDERS; ROSACEA; SEBACEOUS GLANDS; SKIN; VASODILATION;

EID: 4444315851     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.03.030     Document Type: Review

References (153)

1. Wilkin J., Dahl M., Detmar M., Drake L., Feinstein A., Odom R., et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 46:2002;584-587
2. Lonne-Rahm S.B., Fischer T., Berg M. Stinging and rosacea. Acta Derm Venereol. 79:1999;460-461
3. Braun-Falco O., Plewig G., Woff H.H. Dermatologie und Venerologie. 1995;Springer-Verlag, Berlin. p. 963-8
4. Plewig G., Kligman A.M. Acne and rosacea. 3rd ed. :2000;Springer-Verlag, Berlin. p. 433-75
5. Wilkin J.K. Rosacea. Pathophysiology and treatment. Arch Dermatol. 130:1994;359-362
6. Rebora A. Rosacea. J Invest Dermatol. 88:(suppl):1987;56s-60s
7. Dahl M.V. Pathogenesis of rosacea. Adv Dermatol. 17:2001;29-45
8. Greaves M.W., Burova E. Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol. 8:1997;91-100
9. Wilkin J. Why is flushing limited to a mostly facial cutaneous distribution. J Am Acad Dermatol. 19:1988;309-313
10. Marks R., Jones E.W. Disseminated rosacea. Br J Dermatol. 81:1969;16-28
11. Wilkin J.K. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol. 76:1981;15-18
12. Higgins E., du Vivier A. Alcohol intake and other skin disorders. Clin Dermatol. 17:1999;437-441
13. Brinnel H., Friedel J., Caputa M., Cabanac M., Grosshans E. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res. 281:1989;66-72
14. Chen D.M., Crosby D.L. Periorbital edema as an initial presentation of rosacea. J Am Acad Dermatol. 37:1997;346-348
15. Harvey D.T., Fenske N.A., Glass L.F. Rosaceous lymphedema: a rare variant of a common disorder. Cutis. 61:1998;321-324
16. Decauchy F., Beauvais L., Meunier L., Meynadier J. [Rosacea]. Rev Prat. 43:1993;2344-2348. French
17. Sibenge S., Gawkrodger D.J. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol. 26:1992;590-593
18. Jansen T., Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg. 14:1998;241-253
19. Aloi F., Tomasini C., Soro E., Pippione M. The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol. 42:2000;468-472
20. Rohrich R.J., Griffin J.R., Adams W.P. Jr. Rhinophyma: review and update. Plast Reconstr Surg. 110:2002;860-869. Quiz 70
21. Bogetti P., Boltri M., Spagnoli G., Dolcet M. Surgical treatment of rhinophyma: a comparison of techniques. Aesthetic Plast Surg. 26:2002;57-60
22. Irvine C., Kumar P., Marks R. Isotretinoin in the treatment of rosacea and rhinophyma. Marks R., Plewig G. Acne and related disorders: proceedings of an international symposium. 1988;301-305 Martin Dunitz, London
23. Lloyd K.M. Surgical correction of rhinophyma. Arch Dermatol. 126:1990;721-723
24. Nikolowski J., Plewig G. [Oral treatment of rosacea with 13-cis-retinoic acid]. Hautarzt. 32:1981;575-584. German
25. Rebora A. The management of rosacea. Am J Clin Dermatol. 3:2002;489-496
26. Akpek E.K., Merchant A., Pinar V., Foster C.S. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 104:1997;1863-1867
27. Ghanem V.C., Mehra N., Wong S., Mannis M.J., Tanzi E.L., Weinberg J.M., et al. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea. 22:2003;230-233
28. Hoting E., Paul E., Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol. 25:1986;660-663
29. Starr P.A. Oculocutaneous aspects of rosacea. Proc R Soc Med. 62:1969;9-11
30. Quarterman M.J., Johnson D.W., Abele D.C., Lesher J.L. Jr., Hull D.S., Davis L.S. Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 133:1997;49-54
31. Zengin N., Tol H., Gunduz K., Okudan S., Balevi S., Endogru H. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea. 14:1995;144-146
32. Patrinely J.R., Font R.L., Anderson R.L. Granulomatous acne rosacea of the eyelids. Arch Ophthalmol. 108:1990;561-563
33. Macsai M.S., Mannis M.J., Huntley A.C. Acne rosacea. Eye and skin diseases. 1996;335-341 Lippincott-Raven, Philadelphia
34. Browning D.J., Proia A.D. Ocular rosacea. Surv Opthalmol. 31:1986;145-158
35. Jenkins M.S., Brown S.I., Lempert S.L., Weingerg R.J. Ocular rosacea. Am J Ophthalmol. 88:1979;618-622
36. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol. 65:1953;458-463
37. Plewig G., Kligman A.M. Acne rosacea. 3rd ed. :2000;Springer-Verlag, Berlin. p. 472-3
38. Wilkin J.K. Epigastric rosacea. Arch Dermatol. 116:1980;584
39. Dupont C. How common is extrafacial rosacea? [letter] J Am Acad Dermatol. 14:1986;839
40. Gajewska M. Rosacea on common male baldness. Br J Dermatol. 93:1975;63-66
41. Ayres S. Jr. Extrafacial rosacea is rare but does exist. J Am Acad Dermatol. 16:1987;391-392
42. Fisher B.K. The red scrotum syndrome. Cutis. 60:1997;139-141
43. Leyden J.J., Thew M., Kligman A.M. Steroid rosacea. Arch Dermatol. 110:1974;619-622
44. Kligman A.M., Leyden J.J. Adverse effects of fluorinated steroids applied to the face. JAMA. 229:1974;60-62
45. Sneddon I.B. Adverse effect of topical fluorinated corticosteroids in rosacea. Br Med J. 1:1969;671-673
46. Weber G. Rosacea-like dermatitis: contraindication or intolerance reaction to strong steroids. Br J Dermatol. 86:1972;253-259
47. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol. 44:2001;995-998
48. Pabby A., An K.P., Laws R.A. Combination therapy of tetracycline and tacrolimus resulting in rapid resolution of steroid-induced periocular rosacea. Cutis. 72:2003;141-142
49. Williams H.C., Ashworth J., Pembroke A.C., Breathnach S.M. FACE - facial Afro-Caribbean childhood eruption. Clin Exp Dermatol. 15:1990;163-166
50. Frieden I.J., Prose N.S., Fletcher V., Turner M.L. Granulomatous perioral dermatitis in children. Arch Dermatol. 125:1989;369-373
51. Puppin D. Jr., Gueissaz F. Red papules on the face with secondary scarring. Lupus miliaris faciei (LMF). Arch Dermatol. 130:1994;369-370. 72-3
52. Marks R. Rosacea: hopeless hypotheses, marvelous myths, and dermal disorganization. Marks R., Plewig G. Acne and related disorders. 1989;293-299 Martin Dunitz, London
53. Marks R., Beard R.J., Clark M.L., Kwok M., Robertson W.B. Gastrointestinal observations in rosacea. Lancet. 1:1967;739-743
54. Burnstock G. Fine-structural identification of autonomic nerves and their relation to smooth muscle. Prog Brain Res. 34:1971;389-404
55. Hertzman A.B., Randal W.C. Regional differences in the basal and maximal rates of blood flow in the skin. J Appl Physiol. 1:1948;234-241
56. Serjesen P. Cutaneous blood flow and tissue blood exchange. Montagna W., Van Scott E.J., Stoughton R.B. Advances in biology of skin. 1972;191-205 Appleton-Century-Crofts, New York
57. Tur E., Tur M., Maibach H.I., Guy R.H. Basal perfusion of the cutaneous microcirculation: measurements as a function of anatomic position. J Invest Dermatol. 81:1983;446
58. Ryan T.J. The blood vessels of the skin. J Invest Dermatol. 67:1976;110-118
59. Nagasaki T., Brinnel H., Hales J.R., Ogawa T. Selective brain cooling in hyperthermia: the mechanisms and medical implications. Med Hypotheses. 50:1998;203-211
60. Borrie P. The state of the blood vessels of the face in rosacea - I. Br J Dermatol. 67:1955;5-8
61. Borrie P. The state of the blood vessels of the face in rosacea - II. Br J Dermatol. 67:1955;73-75
62. Oates J.A. The carcinoid syndrome. N Engl J Med. 315:1986;702-704
63. Powell F.C., Corbally N., Powell D. Substance P levels in rosacea. Marks R., Plewig G. Acne and related disorders. 1989;307-310 Martin Dunitz, London
64. Powell F.C., Corbally N., Powell D. Substance P and rosacea. J Am Acad Dermatol. 28:1993;132-133
65. Kurkcuoglu N., Alaybeyi F. Substance P immunoreactivity in rosacea. J Am Acad Dermatol. 25:1991;725-726
66. Wollina U. Rhinophyma - unusual expression of simple-type keratins and S100A in sebocytes and abundance of VIP receptor-positive dermal cells. Histol Histopathol. 11:1996;111-115
67. Chowers M.Y., Keller N., Tal R., Barshack I., Lang R., Bar-Meir S., et al. Human gastrin: a Helicobacter pylori-specific growth factor. Gastroenterology. 117:1999;1113-1118
68. Tseng G.Y., Lin H.Y., Perng C.L., Lee F.Y., Lo W.C., Tsay S.H., et al. Influence of Helicobacter pylori on gastric secretion and gastrin release in normal Chinese subjects. Chinese Med J (Engl). 62:1999;217-222
69. Guerrera M., Parodi A., Cipriani C., Divano C., Rebora A. Flushing in rosacea: a possible mechanism. Arch Dermatol Res. 272:1982;311-316
70. Parodi A., Guarrera M., Rebora A. Flushing in rosacea: an experimental approach. Arch Dermatol Res. 269:1980;269-273
71. Burgess TH. Eruptions of the face, head and hands. London; 1849.
72. Haxthausen H. Changes in the skin vessels from protracted action of climatic factors and their significance in various skin diseases. Br J Dermatol. 42:1930;105-125
73. Soybe P. Aetiology and pathogenesis of rosacea. Acta Derm Venereol. 30:1950;137-153
74. Marks R., Harcourt-Webster J.N. Histopathology of rosacea. Arch Dermatol. 100:1969;683-691
75. Ertl G.A., Levine N., Kligman A.M. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol. 130:1994;319-324
76. Bonnar E., Eustace P., Powell F.C. The Demodex mite population in rosacea. J Am Acad Dermatol. 28:1993;443-448
77. Urbach S. Ultraviolet radiation and its relationship to skin cancer in man. Montagna W. Advances in biology of the skin. 1966;Pergamon, Oxford
78. Berg M., Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 69:1989;419-423
79. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 80:1968;170-177
80. Nunzi E., Rebora A., Hamerlinck F., Cormane R.H. Immunopathological studies on rosacea. Br J Dermatol. 103:1980;543-551
81. Goetz H., Cronen J. Die UV-lichtenpfindlichkeit der haut bei der rosacea. Z Hautkr. 55:1980;232-236
82. Brodthagen H. Mepacrine and chloroquine in the treatment of rosacea. Br J Dermatol. 67:1955;421-425
83. Rosen T., Stone M.S. Acne rosacea in blacks. J Am Acad Dermatol. 17:1987;70-73
84. Browning D.J., Rosenwasser G., Lugo M. Ocular rosacea in blacks. Am J Ophthalmol. 101:1986;441-444
85. Kuhn A., Sonntag M., Richter-Hintz D., Oslislo C., Megahed M., Ruzicka T., et al. Phototesting in lupus erythematosus tumidus - review of 60 patients. Photochem Photobiol. 73:2001;532-536
86. Ramelet A.A., Perroulaz G. [Rosacea: histopathologic study of 75 cases]. Ann Dermatol Venereol. 115:1988;801-806. French
87. Neumann E., Frithz A. Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea. Int J Dermatol. 37:1998;263-266
88. Motley R.J., Barton S., Marks R. The significance of telangiectasia in rosacea. Marks R., Plewig G. Acne and related disorders. 1989;339-344 Martin Dunitz, London
89. Helm K.F., Menz J., Gibson L.E., Dicken C.H. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol. 25:1991;1038-1043
90. Nakamuro K., Johnson W.C. Ultraviolet light induced connective tissue changes in rat skin: a histologic and histochemical study. J Invest Dermatol. 51:1968;194-198
91. Einarsson K., Hard S., Lejd B., Neuman E. Intracutaneous herniation of fat in connection with microangiopathia diabetica. Acta Med Scand. 204:1978;137-139
92. Rosset M., Oki G. Skin diseases in alcoholics. Q J Stud Alcohol. 32:1971;1017-1024
93. Reifler D.M., Verdier D.D., Davy C.L., Mostow N.D., Wendt V.E. Multiple chalazia and rosacea in a patient treated with amiodarone. Am J Ophthalmol. 103:1987;594-595
94. Franco H.L., Weston W.L. Steroid rosacea in children. Pediatrics. 64:1979;36-38
95. Savin J.A., Alexander S., Marks R. A rosacea-like eruption of children. Br J Dermatol. 87:1972;425-429
96. Guin J.D. Complications of topical hydrocortisone. J Am Acad Dermatol. 4:1981;417-422
97. Weston W.L., Morelli J.G. Steroid rosacea in prepubertal children. Arch Pediatr Adolesc Med. 154:2000;62-64
98. Egan C.A., Rallis T.M., Meadows K.P., Krueger G.G. Rosacea induced by beclomethasone dipropionate nasal spray. Int J Dermatol. 38:1999;133-134
99. Sherertz E.F. Acneiform eruption due to "megadose" vitamins B6 and B12. Cutis. 48:1991;119-120
100. Jansen T., Romiti R., Kreuter A., Altmeyer P. Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol. 15:2001;484-485
101. Burton J.L., Pye R.J., Meyrick G., Shuster S. The sebum excretion rate in rosacea. Br J Dermatol. 92:1975;541-543
102. Pye R.J., Meyrick G., Burton J.L. Skin surface lipid composition in rosacea. Br J Dermatol. 94:1976;161-164
103. Grosshans E.M., Kremer M., Maleville J. [Demodex folliculorum and the histogenesis of granulomatous rosacea]. Hautarzt. 25:1974;166-177. German
104. Roihu T., Kariniemi A.L. Demodex mites in acne rosacea. J Cutan Pathol. 25:1998;550-552
105. Rufli T., Mumcuoglu Y., Cajcob A., Buchner S. [Demodicidae/follicle mites]. Schweiz Rundsch Med Prax. 70:1981;622-630. German
106. Forton F., Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol. 128:1993;650-659
107. Aylesworth R., Vance J.C. Demodex folliculorum and Demodex brevis in cutaneous biopsies. J Am Acad Dermatol. 7:1982;583-589
108. Basta-Juzbasic A., Subic J.S., Ljubojevic S. Demodex folliculorum in development of dermatitis rosaceiformis steroidica and rosacea-related diseases. Clin Dermatol. 20:2002;135-140
109. Skrlin J., Richter B., Basta-Juzbasic A., Matica B., Ivacic B., Cvrlje M., et al. Demodicosis and rosacea. Lancet. 337:1991;734
110. Hojyo Tomoka M.T., Dominguez Soto L. [Demodecidosis and rosaceiform dermatitis]. Med Cutan Ibero Lat Am. 4:1976;83-90. Spanish
111. Kaufmann-Wolf M. Uber regelmassiges vorkommen von Demodex folliculorum in den puteln von rosacea pustulosa. Dermat Wschr. 81:1925;1095
112. Ayres S.J., Anderson N.P. Acne rosacea: response to local tretment of Demodex folliculorum. JAMA. 100:1933;645
113. Ayres S.J., Ayres S. Demodectic eruptions (demodicidosis) in the human. Arch Dermatol. 83:1961;816-827
114. Sanchez-Viera M., Hernanz J.M., Sampelayo T., Gurbindo M.D., Lecona M., Soto-Melo J. Granulomatous rosacea in a child infected with the human immunodeficiency virus. J Am Acad Dermatol. 27:1992;1010-1011
115. Castanet J., Monpoux F., Mariani R., Ortonne J.P., Lacour J.P. Demodicidosis in an immunodeficient child. Pediatr Dermatol. 14:1997;219-220
116. DuBois. Recherche du Demodex folliculorum hominis dans la peau saine. Ann Dermatol Syph. 1:1910;188-190
117. Andrews J.R.H. The prevalence of hair follicle mites in Caucasian New Zealanders. N Z Med J. 95:1982;451-453
118. Grosshans E., Dungler T., Kien T.T., Kremer M. [Demodex folliculorum and rosacea: experimental and immunological studies]. Z Hautkr. 55:1980;1211-1218. German
119. Marks R. Histogenesis of the inflammatory component of rosacea. Proc R Soc Med. 66:1973;742-745
120. Basta-Juzbasic A., Marinovic T., Dobric I., Bolanca-Bumber S., Sencar J. The possible role of skin surface lipid in rosacea with epithelioid granulomas. Acta Med Croatica. 46:1992;119-123
121. Fuss F. La vie parasitaire due Demodex folliculorum hominis. Ann Derm Syph (Paris). 4:1933;1053-1062
122. Reichers R., Kopf W.W. Cutaneous infestation with Demodex folliculorum in man. J Invest Dermatol. 52:1969;103-106
123. De Dulanto F., Camacho-Martinez F. Demodicidose "gravis." Ann Dermatol Venereol (Paris). 106:1979;699-704
124. Ecker R.I., Winkelmann R.K. Demodex granuloma. Arch Dermatol. 115:1979;343-344
125. Seifert H.W. Demodex folliculorum als ursache eines solitaren tuberkuloiden granulomas. Z Hautkr. 53:1977;540-542
126. Erbagci Z., Ozgoztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol. 37:1998;421-425
127. Roth A.M. Demodex folliculorum in hair follicles of eyelid skin. Ann Ophthalmol. 11:1979;27-40
128. Breckenridge R.L. Infestation of the skin with Demodex folliculorum. Am J Clin Path. 23:1953;348-352
129. Forton F. Demodex et inflammation perifolliculaire chez l'homme revue et observation de 69 biopsies. Ann Dermatol Venereol. 113:1986;1047-1058
130. Persi A., Rebora A. Metronidazole and Demodex folliculorum. Acta Derm Venereol. 61:1981;182-183
131. Aronson I.K., Rumsfield J.A., West D.P., Alexander J., Fischer J.H., Paloucek F.P. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm. 21:1987;346-351
132. Lowe N.J., Henderson T., Millikan L.E., Smith S., Turk K., Parker F. Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial. Cutis. 43:1989;283-286
133. Robinson T.W.E. Demodex folliculorum and rosacea: a clinical and histological study. Arch Dermatol. 92:1965;542-544
134. Utas S., Ozbakir O., Turasan A., Utas C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol. 40:1999;433-435
135. Bamford J.T., Tilden R.L., Gangeness D.E. Does Helicobacter pylori eradication treatment reduce the severity of rosacea? J Am Acad Dermatol. 42:2000;535-536
136. Grilli R. Helicobacter pylori: related to rosacea? J Am Acad Dermatol. 42:2000;536-537
137. Hirschmann J.V. Does Helicobacter pylori have a role in the pathogenesis of rosacea? J Am Acad Dermatol. 42:2000;537-539
138. Rebora A., Drago F. Helicobacter pylori and rosacea. J Am Acad Dermatol. 43:2000;884
139. Rebora A.E. Helicobacter pylori and rosacea. J Eur Acad Dermatol Venereol. 14:2000;344
140. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 272:1994;65-69
141. Pakodi F., Abdel-Salam O.M., Debreceni A., Mozsik G. Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview. J Physiol Paris. 94:2000;139-152
142. Abrahamovych L. [The clinico-morphofunctional status of the esophagogastroduodenal system in patients with acne rosacea: the etiological, pathogenetic and treatment aspects]. Lik Sprava. Oct-Dec(10-12):1996;84-88. Ukrainian
143. Rebora A., Drago F., Parodi A. May Helicobacter pylori be important for dermatologists? Dermatology. 191:1995;6-8
144. Erel A., Oztas M., Ilter N., Senol E., Sultan N., Grurer M.A. Helicobacter pylori seroprevalence in patients with acne rosacea [abstract]. J Eur Acad Dermatol Venereol. 5:1995;151
145. Powell F.C., Daw M.A., Duguid C. Positive Helicobacter pylori serology in rosacea patients. [abstract] Irish J Med Sci. 161:1992;75
146. Szlachcic A., Sliwowski Z., Karczewska E., Bielanski W., Pytko-Polonczyk J., Konturek S.J. Helicobacter pylori and its eradication in rosacea. J Physiol Pharmacol. 50:1999;777-786
147. Schneider M.A., Skinnder R.B.J., Roserberg E.W. Serologic determination of Helicobacter pylori in rosacea patients and controls. [abstract] Clin Res. 40:1992;831
148. Jones M.P., Knable A.L. Jr., White M.J., Durning S.J. Helicobacter pylori in rosacea: lack of an association. Arch Dermatol. 134:1998;511
149. Sharma V.K., Lynn A., Kaminski M., Vasudeva R., Howden C.W. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol. 93:1998;220-222
150. Son S.W., Kim I.H., Oh C.H., Kim J.G. The response of rosacea to eradication of Helicobacter pylori. Br J Dermatol. 140:1999;984-985
151. Herr H., You C.H. Relationship between Helicobacter pylori and rosacea: it may be a myth. J Korean Med Sci. 15:2000;551-554
152. Bamford J.T., Tilden R.L., Blankush J.L., Gangeness D.E. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol. 135:1999;659-663
153. Kosmadaki M.G., Yaar M., Arble B.L., Gilchrest B.A. UV induces VEGF through a TNF-alpha independent pathway. FASEB J. 17:2003;446-448